A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
How effective has the bivalent booster COVID vaccination been?
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Vaccines | Free Full-Text | Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
A quick update on the bivalent boosters - by Eric Topol
Why and When to Get a Bivalent Covid-19 Booster | Johns Hopkins | Bloomberg School of Public Health
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
New Omicron-specific vaccines offer similar protection to existing boosters
Why payers should be preparing now for new COVID-19 boosters
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Evidence to recommendation Framework: Bivalent COVID-19 vaccine booster doses
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
